Drug Approval | July 14, 2023
Granules India announces approval for Acetaminophen and Ibuprofen Tablets
This product will be launched through Granules Consumer Health (GCH) division
This product will be launched through Granules Consumer Health (GCH) division
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Approval to dramatically change CAR-T therapies landscape
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Subscribe To Our Newsletter & Stay Updated
